Skip to main content

Impaired Sexual Function

  • Chapter
  • First Online:
Parkinson’s Disease and Nonmotor Dysfunction

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 2578 Accesses

Abstract

The incidence of impaired sexual function in adults with Parkinson’s disease (PD) is greater than in the general population. Studies have examined different aspects of sexual function among adults with PD and their partners. Comparison groups have included healthy adults matched for age and gender, as well as age-matched controls with chronic, nonneurological disease with motor impairment. Impaired sexual function in PD is most likely multifactorial. Depression, physical disability, and autonomic dysfunction may contribute to the increased prevalence of erectile dysfunction (ED) among men with PD. Given this multifactorial basis, clinicians should routinely assess patient needs. For women with PD, therapeutic interventions and impaired sexual function have not been adequately described. Further research is required to develop treatment for adults with PD and sexual dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Araujo AB, Mohr A, Mckinlay JB. Changes in sexual function in middle aged and older men: longitudinal data from the Massachusetts male aging study. J Am Geriatr Soc. 2004;52:1502–9.

    Article  PubMed  Google Scholar 

  2. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–7.

    Article  PubMed  Google Scholar 

  3. Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762–4.

    Article  PubMed  CAS  Google Scholar 

  4. Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med. 2005;2(3):317–30.

    Article  PubMed  Google Scholar 

  5. Saigal CS, Wesselis H, Pace J, et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166:207–12.

    Article  PubMed  Google Scholar 

  6. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.

    Article  PubMed  CAS  Google Scholar 

  7. Johannes CB, Araujo AB, Feldman HA, et al. Incidence of erectile dysfunction in men 40–69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163:460–3.

    Article  PubMed  CAS  Google Scholar 

  8. Blanker MH, Bohnen AM, Groeneveld FP, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community based study. J Am Geriatr Soc. 2001;49:436–42.

    Article  PubMed  CAS  Google Scholar 

  9. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the epidemiologia de la disfuncion erectil masculina study. J Urol. 2001;166:569–75.

    Article  PubMed  CAS  Google Scholar 

  10. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the “Cologne Male Survey”. Int J Impot Res. 2000;12:305–11.

    Article  PubMed  CAS  Google Scholar 

  11. Chew KK, Earle CM, Stuckey BG, et al. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res. 2000;12:41–5.

    Article  PubMed  CAS  Google Scholar 

  12. Bacon CG, Mittelman MA, Kawachi I, Giovannucci E. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003;139:161–8.

    PubMed  Google Scholar 

  13. McVary KT. Clinical practice. Erectile dysfunction. N Engl J Med. 2007;357:2472–81.

    Article  PubMed  CAS  Google Scholar 

  14. Gazzaruso C, Giodanetti S, DeAmici E, et al. Relationship between erectile dysfunction, and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004;110:22–6.

    Article  PubMed  Google Scholar 

  15. DeBerardis G, Pellegrini F, Franciosi M, et al. Identifying with type 2 diabetes with higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors. J Urol. 2003;169:1422–8.

    Article  Google Scholar 

  16. Morely JE, Haren MT, Kim MJ, et al. Testosterone, aging and quality of life. J Endocrinol Invest. 2005;28:76–80.

    Google Scholar 

  17. Chiurla E, D’Amico R, Ratti C, et al. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol. 2005;46:1503–6.

    Article  Google Scholar 

  18. National Kidney and Urologic Diseases Clearing house. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH diseases. Available at http://kidney.niddk.nih.gov/kudiseases/pubs/impotence. Accessed 10 Feb 2010.

  19. Masters W, Johnson V. Human sexual response. Boston: Little Brown; 1966.

    Google Scholar 

  20. Kaplan HS. The new sex therapy. New York: Brunner/Mazel; 1974.

    Google Scholar 

  21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Washington DC: American Psychiatric Association; 2000.

    Google Scholar 

  22. Shifren JL. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112:970–8.

    Article  PubMed  Google Scholar 

  23. Fugl-Meyer AR, Fugl-Meyer K. Sexual difficulties, problems, and satisfaction in 18-74 year old Swedes. Scand J Sexol. 1999;2:79–105.

    Google Scholar 

  24. Witting K, Santtila P, Varjonen M, Jern P, Johansson A, von der Pahlen B, Sandnabba K. Female sexual dysfunction, sexual distress, and compatibility with partner. J Sex Med. 2008;5(11):2587–99.

    Article  PubMed  Google Scholar 

  25. Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav. 2003;32:193–208.

    Article  PubMed  Google Scholar 

  26. Burguera JA, Garcia Reboll L, Martinez Agullo E. Sexual dysfunction in Parkinson’s disease. Neurologia. 1994;9:178–81.

    PubMed  CAS  Google Scholar 

  27. Jacobs H, Vieregge A, Vieregge P. Sexuality in young patients with Parkinson ’s disease: a population based comparison with healthy controls. J Neurol Neurosurg Psychiatry. 2000;69:550–2.

    Article  PubMed  CAS  Google Scholar 

  28. Fahn S, Elton RI, Members of the UPDRS Development Committee. Unified Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, editors. Recent developments in Parkinson’s disease II. Florham Park: MacMillan; 1987. p. 153–63.

    Google Scholar 

  29. Hoehn M, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–42.

    Article  PubMed  CAS  Google Scholar 

  30. Schneider HD. Sexualverhalten in der zweiten Lebenshalfte: Ergebnisse sozialwissenschaftlicher Forschung. Stuttgart: Kohl-hammer; 1980.

    Google Scholar 

  31. Von Zerssen D, Koeller DM. Paranoid-Depressivitats-Skala. Weinheim: Beltz Test; 1976.

    Google Scholar 

  32. Wechsler D. Handanweisung zum Hamburg-Weschler-Intelligenztest fur Erwachsene (HAWIE). Bern: Hans Huber; 1982.

    Google Scholar 

  33. Wermuth L, Stenager E. Sexual problems in young patients with Parkinson’s disease. Acta Neurol Scand. 1995;91:453–5.

    Article  PubMed  CAS  Google Scholar 

  34. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7:151–69.

    PubMed  CAS  Google Scholar 

  35. Hand A, Gray WK, Chandler BJ, Walker RW. Sexual and relationship dysfunction in people with Parkinson disease. Parkinsonism Relat Disord. 2010;16:172–6.

    Article  PubMed  Google Scholar 

  36. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: review of the development, validation, and application of Parkinson’s disease quality of life questionnaire and its associated measures. J Neurol. 1998;245:510–4.

    Article  Google Scholar 

  37. Folstein MF, Folstein SE, Mchugh PR. Mini-mental state-a practical method for grading cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

    Article  PubMed  CAS  Google Scholar 

  38. Szasz G, Paty D, Lawtonspeert S, Eisen K. A sexual functioning scale in multiple sclerosis. Acta Neurol Scand. 1984;70:37–43.

    Article  Google Scholar 

  39. Rust J, Bennun I, Crowe M, Golombok S. The Golombok-Rust inventory of marital state. Sex Marital Ther. 1988;1:55–60.

    Article  Google Scholar 

  40. Celikel E, Ozel-kizil ET, Akbostanci MC, Cevik A. Assessment of sexual dysfunction in patients with Parkinson’s disease: a case control study. Eur J Neurol. 2008;15:1168–72.

    Article  PubMed  CAS  Google Scholar 

  41. McGahuey CA, Gelenberg AJ, Laukes CA, et al. Arizona sexual experience scale (ASEX); reliability and validity. J Sex Marital Ther. 2000;26:25–40.

    Article  PubMed  CAS  Google Scholar 

  42. Williams BW. A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry. 1988;45:742–7.

    Article  PubMed  CAS  Google Scholar 

  43. Hamilton M. The assessments of anxiety states by rating. Br J Med Psychol. 1959;32:50.

    Article  PubMed  CAS  Google Scholar 

  44. Koller WC, Vetere-Overfeld B, Williamson A, et al. Sexual dysfunction in Parkinson’s disease. Clin Neuropharmacol. 1990;13:461–3.

    Article  PubMed  CAS  Google Scholar 

  45. Brown RG, Jahanshahi M, Quinn N, Marsden CD. Sexual function in patients with Parkinson’s disease and their partners. J Neurol Neurosurg Psychiatry. 1990;53:480–6.

    Article  PubMed  CAS  Google Scholar 

  46. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982–1983;17:37–49.

    Article  Google Scholar 

  47. Othmer E, Othmer SC. Evaluation of sexual dysfunction. J Clin Psychiatry. 1987;48:191–3.

    PubMed  CAS  Google Scholar 

  48. Rust J, Golombok S. The Golombok Rust Inventory of Sexual Satisfaction. Windsor: NFER-Nelson; 1986.

    Google Scholar 

  49. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press; 1970.

    Google Scholar 

  50. Felton BJ, Revenson TA. Coping with chronic illness: a study of illness controllability and the influence of coping strategies on psychological adjustment. J Consult Clin Psychol. 1984;52:343–53.

    Article  PubMed  CAS  Google Scholar 

  51. Robinson BC. Validation of a Caregiver Strain Index. J Gerontol. 1983;38:344–8.

    Article  PubMed  CAS  Google Scholar 

  52. Singer C, Weiner WJ, Sanchez-Ramos J. Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol. 1992;32:134–40.

    Article  PubMed  CAS  Google Scholar 

  53. Gao X, Honglei C, Schwarzschild MA, et al. Erectile function and risk of Parkinson’s Disease. Am J Epidemiol. 2007;166:1446–50.

    Article  PubMed  Google Scholar 

  54. Lipe H, Longstreth Jr WT, Bird TD, Linde M. Sexual function in married men with Parkinson’s disease compared to married men with arthritis. Neurology. 1990;40:1347–9.

    Article  PubMed  CAS  Google Scholar 

  55. Yahr MD, Duvoisin RC, Schear MJ, et al. Treatment of Parkinsonism with levodopa. Arch Neurol. 1969;21:343–54.

    Article  PubMed  CAS  Google Scholar 

  56. Steinbrocker O, Traeyer CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140:659–62.

    Article  CAS  Google Scholar 

  57. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70.

    Article  PubMed  CAS  Google Scholar 

  58. Watts RJ. Sexual functioning, health beliefs, and compliance with high blood pressure medications. Nurs Res. 1982;31:278–83.

    PubMed  CAS  Google Scholar 

  59. Welsh M, Hung L, Waters CH. Sexuality in women with Parkinson’s disease. Mov Disord. 1997;12:923–7.

    Article  PubMed  CAS  Google Scholar 

  60. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav. 1994;23:627–43.

    Article  PubMed  CAS  Google Scholar 

  61. Shabsigh R, Anastasiadis AG. Erectile dysfunction. Annu Rev Med. 2003;54:153–68.

    Article  PubMed  CAS  Google Scholar 

  62. Berman JR, Berman L, Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology. 1999;54:385–91.

    Article  PubMed  CAS  Google Scholar 

  63. McCarty T, Fromm L, Weiss-Roberts L. et al. In: Copeland L, editor. Textbook of gynecology. Philadelphia: Saunders; 2000. p. 475–85.

    Google Scholar 

  64. Berman JR. Physiology of female sexual function and dysfunction. Int J Impot Res. 2005;17:s44–51.

    Article  PubMed  Google Scholar 

  65. Sarrel PM. Sexuality and menopause. Obstet Gynecol. 1990;75(4 Suppl):26S–30.

    PubMed  CAS  Google Scholar 

  66. O’Sullivan JD, Hughes AJ. Apomorphine-induced penile erections in Parkinson’s disease. Mov Disord. 1998;13:536–9.

    Article  PubMed  Google Scholar 

  67. WHO Regional Strategy on Sexual and Reproductive Health Reproductive Pregnancy Health Programme. Copenhagen, Denmark, November 2001, p. 7. http://www.euro.who.int/document/e74558.pdf. Accessed 10 Feb 2010.

  68. Jardin A, Wagner G, Khoury S, et al. Recommendations of the first international consultation on erectile dysfunction. In: Jardin A, Wagner G, Khoury S, et al., editors. Erectile dysfunction. Plymouth: Plymbridge Dist; 2000. p. 711–26.

    Google Scholar 

  69. Okun MS, McDonald WM, DeLong MR. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol. 2002;59:807–11.

    Article  PubMed  Google Scholar 

  70. Okun M, Fernandez H, Rodriguez R, et al. Testosterone therapy in men with Parkinson disease. Arch Neurol. 2006;63:729–35.

    Article  PubMed  Google Scholar 

  71. Zesiewicz TA, Helal M, Hauser RA. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson’s disease. Mov Disord. 2000;15:305–8.

    Article  PubMed  CAS  Google Scholar 

  72. Hussain IF, Brady CM, Swinn MJ, et al. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in Parkinsonism due to Parkinson’s disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2001;71:371–4.

    Article  PubMed  CAS  Google Scholar 

  73. Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2010;74:924–31.

    Article  PubMed  CAS  Google Scholar 

  74. Cohan P, Korenman SG. Erectile dysfunction. J Clin Endocrinol Metab. 2001;86:2391–4.

    Article  PubMed  CAS  Google Scholar 

  75. Carani C, Scuteri A, Marrama P, Bancroft J. The effects of testosterone administration and visual erotic stimuli on nocturnal penile tumescence in normal men. Horm Behav. 1990;24:435–41.

    Article  PubMed  CAS  Google Scholar 

  76. Bhasin S. The dose-dependent effects of testosterone on sexual function and on muscle mass and function. Mayo Clin Proc. 2000;75:S75–6.

    Article  Google Scholar 

  77. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49:1239–42.

    Article  PubMed  CAS  Google Scholar 

  78. Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am. 2001;28:321–34.

    Article  PubMed  CAS  Google Scholar 

  79. Wespes E, Amar E, Hatzichristou D, et al. Guidelines on erectile dysfunction. Eur Urol. 2002;41:1–5.

    Article  PubMed  Google Scholar 

  80. Fink, HA, MacDonald R, Wilt TJ. Diagnosis and treatment of erectile dysfunction. AHRQ Publication No. 08(09)-E016 May 2009. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=hserta&part=B163619. Accessed 10 Feb 2010.

  81. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged 5-item version of the International Index of Erectile Dysfunction (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–26.

    Article  PubMed  CAS  Google Scholar 

  82. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    Article  PubMed  CAS  Google Scholar 

  83. Lal S, Laryea E, Thavundayil JX, et al. Apomorphine induced penile tumescence in impotent patients – preliminary findings. Prog Neuropsychopharmacol Biol Psychiatry. 1987;11:235–42.

    Article  PubMed  CAS  Google Scholar 

  84. Gower AJ, Berendsen HG, Princen MM, Broekkamp CLE. The yawning-penile erection syndrome as a putative model for dopamine autoreceptor activity. Eur J Pharmacol. 1984;103:81–9.

    Article  PubMed  CAS  Google Scholar 

  85. Nair NP, Lal S, Iskandar HI, et al. Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion. Brain Res Bull. 1982;8:587–91.

    Article  PubMed  CAS  Google Scholar 

  86. Lal S, Nair NP, Iskandar HL, et al. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men. J Neural Transm. 1982;54:75–84.

    Article  PubMed  CAS  Google Scholar 

  87. Argiolas A, Melis MR, Mauri A, Gessa GL. Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not ACTH in rats. Brain Res. 1987;421:349–52.

    Article  PubMed  CAS  Google Scholar 

  88. Heaton JP, Morales A, Adams MA, et al. Recovery of erectile function by the oral administration of apomorphine. Urology. 1995;45:200–6.

    Article  PubMed  CAS  Google Scholar 

  89. Horita H, Sato Y, Adachi H, et al. Effects of levodopa on nocturnal penile tumescence: a preliminary study. J Androl. 1998;19:619–34.

    PubMed  CAS  Google Scholar 

  90. Bowers MB, Van Woert M, Davis L. Sexual behavior during L-dopa treatment for Parkinsonism. Am J Psychiatry. 1971;127:1691–3.

    PubMed  Google Scholar 

  91. Brown E, et al. Sexual function and affect in Parkinsonian men treated with L-dopa. Am J Psychiatry. 1978;135:1552–5.

    PubMed  CAS  Google Scholar 

  92. O’Brien CP, DiGiacomo JN, Fahn S. Mental effects of high-dosage levodopa. Arch Gen Psychiatry. 1971;24:61–4.

    Article  PubMed  Google Scholar 

  93. Sandyk R. AC pulsed electromagnetic fields-induced sexual arousal and penile erections in Parkinson’s disease. Int J Neurosci. 1999;99:139–49.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cheryl Waters M.D., F.R.C.P. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Waters, C., Smolowitz, J. (2013). Impaired Sexual Function. In: Pfeiffer, R.F., Bodis-Wollner, I. (eds) Parkinson’s Disease and Nonmotor Dysfunction. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-429-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-429-6_11

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-428-9

  • Online ISBN: 978-1-60761-429-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics